Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

15.8%

3 terminated out of 19 trials

Success Rate

78.6%

-7.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results79% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (5)
P 1 (9)
P 2 (2)

Trial Status

Completed11
Terminated3
Recruiting3
Unknown2

Trial Success Rate

78.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT02565433Not ApplicableTerminatedPrimary

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

NCT05419518Phase 2RecruitingPrimary

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

NCT02246634Not ApplicableRecruiting

Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)

NCT02808416Phase 1Completed

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)

NCT02953756CompletedPrimary

Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)

NCT00152906Phase 1Completed

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

NCT01336985Phase 1TerminatedPrimary

Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads

NCT01122199Phase 1CompletedPrimary

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

NCT02789371Not ApplicableUnknown

Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions

NCT01970644TerminatedPrimary

Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases

NCT02382653Not ApplicableCompletedPrimary

Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain

NCT00556049Phase 2Completed

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

NCT01273493Phase 1CompletedPrimary

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

NCT01267084Phase 1CompletedPrimary

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

NCT02327065Not ApplicableUnknown

Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion

NCT01273480Phase 1CompletedPrimary

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

NCT00668382Phase 1CompletedPrimary

Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection

NCT00184353CompletedPrimary

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

Showing all 19 trials

Research Network

Activity Timeline